ĐÁNH GIÁ CHẤT LƯỢNG XÉT NGHIỆM ĐÔNG MÁU TRONG VÀ NGOÀI NƯỚC

Abstract

Objective: External quality assessment (EQA) in laboratory testing has gained increasing attention in recent years. This study aims to synthesize the results of EQA programs for coagulation testing implemented both nationally and internationally. Methods: A comprehensive review was conducted based on original research articles selected from over 60 publications that met eligibility criteria. These articles were sourced from major electronic databases including PubMed, ScienceDirect, ProQuest, Eli Lilly and Co, and Med Lab Sci, with publication dates ranging from 1977 to 2023, in accordance with PRISMA 2020 guidelines. Results: EQA programs for coagulation testing have been implemented since the 1960s, initially through voluntary schemes by organizations such as the College of American Pathologists (CAP) in the United States, and have since expanded globally. Major organizations like WHO, UKNEQAS, and various national institutions have established EQA programs in numerous countries—from developed nations such as the United States, Germany, and the United Kingdom to developing countries such as Indonesia, Thailand, and Vietnam. Conclusion: EQA programs for coagulation testing play a vital role in ensuring the accuracy and reliability of laboratory results. They contribute to the standardization of testing methods and the improvement of global healthcare quality. These programs facilitate early detection of coagulation disorders, enhance laboratory procedures, and promote international collaboration, thereby ensuring more accurate diagnosis and treatment for patients.